PURE Bioscience Announces Exercise of Over-Allotment Option by Aegis …

SAN DIEGO — PURE Bioscience, Inc. (NASDAQ: PURE), the creator of the patented silver dihydrogen citrate (SDC) antimicrobial, today announced the exercise of the over-allotment option granted to the underwriters to purchase 557,615 additional common …
See all stories on this topic »